Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine
Biomaterials intentionally designed to support the expansion, differentiation, and three-dimensional (3D) culture of induced-pluripotent stem cells (iPSCs) may pave the way to cell-based therapies for chronic respiratory diseases. These conditions are endured by millions of people worldwide and repr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.647834/full |
id |
doaj-7985bcb54fda4db79d60513d8e80fad6 |
---|---|
record_format |
Article |
spelling |
doaj-7985bcb54fda4db79d60513d8e80fad62021-04-08T04:34:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-04-01810.3389/fmed.2021.647834647834Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative MedicineDonald R. Campbell0Christiana N. Senger1Amy L. Ryan2Amy L. Ryan3Chelsea M. Magin4Chelsea M. Magin5Chelsea M. Magin6Department of Bioengineering, Denver, Anschutz Medical Campus, University of Colorado, Aurora, CO, United StatesDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Hastings Center for Pulmonary Research, University of Southern California, Los Angeles, CA, United StatesDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Hastings Center for Pulmonary Research, University of Southern California, Los Angeles, CA, United StatesDepartment of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Bioengineering, Denver, Anschutz Medical Campus, University of Colorado, Aurora, CO, United StatesDepartment of Pediatrics, Anschutz Medical Campus, University of Colorado, Aurora, CO, United StatesDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, United StatesBiomaterials intentionally designed to support the expansion, differentiation, and three-dimensional (3D) culture of induced-pluripotent stem cells (iPSCs) may pave the way to cell-based therapies for chronic respiratory diseases. These conditions are endured by millions of people worldwide and represent a significant cause of morbidity and mortality. Currently, there are no effective treatments for the majority of advanced lung diseases and lung transplantation remains the only hope for many chronically ill patients. Key opinion leaders speculate that the novel coronavirus, COVID-19, may lead to long-term lung damage, further exacerbating the need for regenerative therapies. New strategies for regenerative cell-based therapies harness the differentiation capability of human iPSCs for studying pulmonary disease pathogenesis and treatment. Excitingly, biomaterials are a cell culture platform that can be precisely designed to direct stem cell differentiation. Here, we present a closer look at the state-of-the-art of iPSC differentiation for pulmonary engineering, offer evidence supporting the power of biomaterials to improve stem cell differentiation, and discuss our perspective on the potential for tissue-informed biomaterials to transform pulmonary regenerative medicine.https://www.frontiersin.org/articles/10.3389/fmed.2021.647834/fulldisease modelingregenerative medicinepulmonaryhydrogeltissue-informed engineeringbiomaterials |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Donald R. Campbell Christiana N. Senger Amy L. Ryan Amy L. Ryan Chelsea M. Magin Chelsea M. Magin Chelsea M. Magin |
spellingShingle |
Donald R. Campbell Christiana N. Senger Amy L. Ryan Amy L. Ryan Chelsea M. Magin Chelsea M. Magin Chelsea M. Magin Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine Frontiers in Medicine disease modeling regenerative medicine pulmonary hydrogel tissue-informed engineering biomaterials |
author_facet |
Donald R. Campbell Christiana N. Senger Amy L. Ryan Amy L. Ryan Chelsea M. Magin Chelsea M. Magin Chelsea M. Magin |
author_sort |
Donald R. Campbell |
title |
Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine |
title_short |
Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine |
title_full |
Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine |
title_fullStr |
Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine |
title_full_unstemmed |
Engineering Tissue-Informed Biomaterials to Advance Pulmonary Regenerative Medicine |
title_sort |
engineering tissue-informed biomaterials to advance pulmonary regenerative medicine |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2021-04-01 |
description |
Biomaterials intentionally designed to support the expansion, differentiation, and three-dimensional (3D) culture of induced-pluripotent stem cells (iPSCs) may pave the way to cell-based therapies for chronic respiratory diseases. These conditions are endured by millions of people worldwide and represent a significant cause of morbidity and mortality. Currently, there are no effective treatments for the majority of advanced lung diseases and lung transplantation remains the only hope for many chronically ill patients. Key opinion leaders speculate that the novel coronavirus, COVID-19, may lead to long-term lung damage, further exacerbating the need for regenerative therapies. New strategies for regenerative cell-based therapies harness the differentiation capability of human iPSCs for studying pulmonary disease pathogenesis and treatment. Excitingly, biomaterials are a cell culture platform that can be precisely designed to direct stem cell differentiation. Here, we present a closer look at the state-of-the-art of iPSC differentiation for pulmonary engineering, offer evidence supporting the power of biomaterials to improve stem cell differentiation, and discuss our perspective on the potential for tissue-informed biomaterials to transform pulmonary regenerative medicine. |
topic |
disease modeling regenerative medicine pulmonary hydrogel tissue-informed engineering biomaterials |
url |
https://www.frontiersin.org/articles/10.3389/fmed.2021.647834/full |
work_keys_str_mv |
AT donaldrcampbell engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT christianansenger engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT amylryan engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT amylryan engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT chelseammagin engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT chelseammagin engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine AT chelseammagin engineeringtissueinformedbiomaterialstoadvancepulmonaryregenerativemedicine |
_version_ |
1721535397431869440 |